Current and Novel Inhibitors of HIV Protease

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F09%3A10000884" target="_blank" >RIV/00216208:11310/09:10000884 - isvavai.cz</a>

Alternative codes found

RIV/61388963:_____/09:00336551 RIV/00216208:11120/09:00002242

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Current and Novel Inhibitors of HIV Protease

Original language description

This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, side-effects, and resistance profiles. The compounds in the various stages of clinical development arealso introduced, as well as alternative approaches, aiming at other functional domains of HIV PR. The potential of these novel compounds to open new way to the rational drug design of human viruses is critically assessed.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

CE - Biochemistry

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Viruses

ISSN

1999-4915

e-ISSN

—

Volume of the periodical

1

Issue of the periodical within the volume

3

Country of publishing house

CH - SWITZERLAND

Number of pages

31

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—